Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma, CANbridge Pharma  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma
NCT02044692: The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients

Unknown status
N/A
34
RoW
Green Cross Corporation
Hunter Syndrome
01/20
01/20

Download Options